Animal and Poultry Production, Animal Wealth Development Department, Faculty of Veterinary Medicine, Benha University, Benha, Egypt.
Veterinary Economics and Farm Management, Animal Wealth Development Department, Faculty of Veterinary Medicine, Benha University, Benha, Egypt.
Vet Med Sci. 2021 May;7(3):773-791. doi: 10.1002/vms3.412. Epub 2021 Mar 15.
The poultry farms need a safe and effective alternative for antibiotics that can counteract the negative impacts of necrotic enteritis (NE), which causes severe mortalities and economic losses. The current study was aimed to examine the influence of antibiotic (Flagymox) and the microbial-based administration on carcass traits in Clostridium (C.) perfringens-infected Cobb and Arbor Acres broilers. A total number of 360 Cobb and Arbor Acres broiler chicks (180 numbers per breed) were allocated to four groups; negative control group (without any treatments); positive control group (administration of C. perfringens at the rate of 1 × 10 cfu/bird via crop gavage twice daily from day 16 to 18 post-hatch); C. perfringens challenge plus antibiotic (Flagymox ) group, and Clostridium perfringens challenge plus microbial-based treatment (Big-lactoα ) group. The results indicated that the Flagymox and Big-lactoα treated Cobb breed group achieved a significant increase in their body weight (BW) than the positive control group at the third week post-infection. Also, the Arbor Acres breed gained significantly higher weight compared to the Cobb breed at the third week. Total weight gain (TWG) from 0 to the fifth week in the Cobb and Arbor Acres breeds were higher in the groups treated with Flagymox and Big-lactoα compared to the birds challenged with C. perfringens without any treatment, thus, increasing the total return (TR) in the treated groups. Economic efficiency showed no significant differences (p < .05) between the treatment groups of both the breeds. Although the treatment cost of Flagymox is higher than the microbial-based treatment (0.86 versus 0.35 LE), there were no mortalities reported in the microbial-based groups in both the breeds resulting in significantly low losses compared to the Flagymox treated groups. The groups treated with the microbial-based products in both breeds were superior in dressing percentage (75.16 and 77.06% for Cobb and Arbor Acres, respectively) compared to that of the other groups. In conclusion, microbial-based therapy improved the growth rate, carcass traits, survival rate, and economic efficiency in necrotic enteritis induced in Cobb and Arbor Acres broilers.
家禽养殖场需要一种安全有效的抗生素替代品来对抗坏死性肠炎 (NE) 的负面影响,这种疾病会导致严重的死亡率和经济损失。本研究旨在研究抗生素(Flagymox)和基于微生物的管理对感染产气荚膜梭菌的科布和阿伯丁·雅可肉鸡的屠体特性的影响。将 360 只科布和阿伯丁·雅可肉鸡雏鸡(每个品种 180 只)分配到四个组;阴性对照组(不进行任何处理);阳性对照组(从孵化后第 16 天至第 18 天,每天通过口腔灌胃两次给予 1×10cfu/只产气荚膜梭菌);产气荚膜梭菌感染加抗生素(Flagymox)组和产气荚膜梭菌感染加基于微生物的治疗(Big-lactoα)组。结果表明,在感染后第三周,Flagymox 和 Big-lactoα 处理的科布品种组的体重(BW)比阳性对照组显著增加。此外,阿伯丁·雅可品种在第三周的体重也显著高于科布品种。科布和阿伯丁·雅可品种从第 0 周到第 5 周的总增重(TWG)在接受 Flagymox 和 Big-lactoα 治疗的组中高于未接受产气荚膜梭菌治疗的组,从而增加了治疗组的总回报(TR)。两种品种的治疗组之间的经济效益没有显著差异(p<0.05)。虽然 Flagymox 的治疗成本高于基于微生物的治疗(0.86 与 0.35 利尔),但在两种品种中,基于微生物的治疗组均未报告死亡,与 Flagymox 治疗组相比,损失明显较低。两种品种中使用基于微生物产品的组在屠体率(科布为 75.16%,阿伯丁·雅可为 77.06%)方面均优于其他组。总之,基于微生物的治疗改善了科布和阿伯丁·雅可肉鸡坏死性肠炎诱导的生长速度、屠体特性、存活率和经济效益。